Rapport Closes Stock, Warrant and Convertible Note Offerings
Rapport Therapeutics also said underwriters fully exercised their options to purchase additional shares and notes, alongside a concurrent private placement.
Story updates
12:02:42 PM UTC
SquawkNews
Rapport Announces Closing of Public Offerings of Common Stock and Pre-Funded Warrants and Convertibl
12:05:22 PM UTC
SquawkNews
Rapport closed its previously announced underwritten offerings of 9.76 mln common shares at $21.00/s
12:08:41 PM UTC
SquawkNews
Rapport closed stock and convertible-note offerings, including the full exercise of underwriters’ options, raising approximately $410.7M in net proceeds. The company expects its cash, including proceeds, to fund operations through the end of 2029.Material DetailsContext by AI AnalystThis financing…
12:09:02 PM UTC
SquawkNews
Rapport Therapeutics closes $172.5 million convertible senior notes offering Rapport Therapeutic